Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
作者信息
Horisberger Alice, Moi Laura, Ribi Camillo, Comte Denis
机构信息
Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland
出版信息
Lupus Sci Med. 2020 May;7(1). doi: 10.1136/lupus-2020-000408.
Abstract
摘要
相似文献
1
Impact of COVID-19 pandemic on SLE: beyond the risk of infection.2019冠状病毒病大流行对系统性红斑狼疮的影响：超越感染风险
Lupus Sci Med. 2020 May;7(1). doi: 10.1136/lupus-2020-000408.
2
Respiratory protection during the COVID-19 pandemic - the evidence shows it works: Author's response to Mandal et al., 2020.2019冠状病毒病大流行期间的呼吸防护——证据表明其有效：作者对Mandal等人2020年文章的回应
Int J Nurs Stud. 2020 Sep;109:103717. doi: 10.1016/j.ijnurstu.2020.103717. Epub 2020 Jul 18.
3
The COVID-19 Pandemic: We Are All in This Together.新冠疫情：我们同处风雨共担。
Clin Infect Dis. 2020 Jul 28;71(15):892-893. doi: 10.1093/cid/ciaa369.
4
Dermatology staff participate in fight against Covid-19 in China.中国皮肤科医护人员参与抗击新冠疫情。
J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211. doi: 10.1111/jdv.16390.
5
Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.2019年冠状病毒病大流行期间羟氯喹短缺对系统性红斑狼疮患者的潜在后果
J Rheumatol. 2020 Jun 1;47(6):787-790. doi: 10.3899/jrheum.200395. Epub 2020 Apr 8.
6
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Feb 5;16(680):296.
7
Water, climate change, and COVID-19: prioritising those in water-stressed settings.水、气候变化与2019冠状病毒病：优先关注水资源紧张地区的人群。
Lancet Planet Health. 2020 May;4(5):e175. doi: 10.1016/S2542-5196(20)30084-X.
8
The Race to Develop a COVID-19 Vaccine.新冠疫苗研发竞赛。
Am J Nurs. 2020 Oct;120(10):14-15. doi: 10.1097/01.NAJ.0000718556.85319.00.
9
Fast, portable tests come online to curb coronavirus pandemic.快速、便捷的检测上线以遏制新冠疫情。
Nat Biotechnol. 2020 May;38(5):515-518. doi: 10.1038/d41587-020-00010-2.
10
Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?2019新型冠状病毒（严重急性呼吸综合征冠状病毒2）：一场需要新应对方法的全球紧急情况？
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2162-2164. doi: 10.26355/eurrev_202002_20396.
引用本文的文献
1
Exploring the complex relationship between systemic lupus erythematosus and coronavirus disease 2019: genetic insights and potential protective mechanisms.探索系统性红斑狼疮与2019冠状病毒病之间的复杂关系：遗传学见解与潜在保护机制。
J Glob Health. 2025 Jul 11;15:04191. doi: 10.7189/jogh.15.04191.
2
COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.COVID-19 预后在系统性红斑狼疮与类风湿关节炎和脊柱关节炎中的比较：来自意大利风湿病学会的 CONTROL-19 研究的结果。
Lupus Sci Med. 2023 Oct;10(2). doi: 10.1136/lupus-2023-000945.
3
Dysregulation of immunity in COVID-19 and SLE.COVID-19 与系统性红斑狼疮中的免疫失调。
Inflammopharmacology. 2022 Oct;30(5):1517-1531. doi: 10.1007/s10787-022-01047-2. Epub 2022 Aug 26.
4
Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.系统性红斑狼疮中诊断基因标志物的鉴定及免疫浸润
Comput Math Methods Med. 2022 May 10;2022:3386999. doi: 10.1155/2022/3386999. eCollection 2022.
5
Use of Monoclonal Antibodies Therapy for Treatment of Mild to Moderate COVID-19 in 4 Patients with Rheumatologic Disorders.4 例风湿免疫病患者应用单克隆抗体治疗轻中度 COVID-19。
Med Sci Monit. 2021 Nov 25;27:e934267. doi: 10.12659/MSM.934267.
6
Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.系统性红斑狼疮患者新冠病毒肺炎住院率：丹麦全国队列研究
J Clin Med. 2021 Aug 27;10(17):3842. doi: 10.3390/jcm10173842.
7
Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID-19 infection: A case report with detailed laboratory data.1例新型冠状病毒肺炎感染后系统性红斑狼疮患者口服类固醇和羟氯喹治疗成功：附详细实验室数据的病例报告
Clin Case Rep. 2021 Aug 24;9(8):e04700. doi: 10.1002/ccr3.4700. eCollection 2021 Aug.
8
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.新型冠状病毒肺炎：揭开新兴的严重急性呼吸系统综合征冠状病毒 2 变种、疫苗和治疗策略的神秘面纱。
Biomolecules. 2021 Jul 6;11(7):993. doi: 10.3390/biom11070993.
9
The Epidemiology of COVID-19 and MS-Related Characteristics in a National Sample of People With MS in China.中国全国多发性硬化症患者样本中新冠病毒肺炎的流行病学及与多发性硬化症相关的特征
Front Neurol. 2021 May 28;12:682729. doi: 10.3389/fneur.2021.682729. eCollection 2021.
10
COVID-19 illness and autoimmune diseases: recent insights.COVID-19 疾病与自身免疫性疾病：最新见解。
Inflamm Res. 2021 Apr;70(4):407-428. doi: 10.1007/s00011-021-01446-1. Epub 2021 Feb 28.
本文引用的文献
1
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy.长期肝移植患者中的新型冠状病毒肺炎：来自意大利伦巴第地区一家移植中心的初步经验。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):532-533. doi: 10.1016/S2468-1253(20)30116-3. Epub 2020 Apr 9.
2
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.表观遗传调控 ACE2 和干扰素调节基因可能提示狼疮患者 COVID-19 的易感性和严重程度增加。
Clin Immunol. 2020 Jun;215:108410. doi: 10.1016/j.clim.2020.108410. Epub 2020 Apr 8.
3
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.在 COVID-19 大流行期间使用羟氯喹和氯喹：每个临床医生都应该知道的事。
Ann Intern Med. 2020 Jun 2;172(11):754-755. doi: 10.7326/M20-1334. Epub 2020 Mar 31.
4
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
5
Novel paradigms in systemic lupus erythematosus.系统性红斑狼疮的新范式。
Lancet. 2019 Jun 8;393(10188):2344-2358. doi: 10.1016/S0140-6736(19)30546-X. Epub 2019 Jun 6.
6
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?风湿炎症性疾病中巨噬细胞活化综合征的免疫发病机制研究进展：新的治疗靶点？
Expert Rev Clin Immunol. 2017 Nov;13(11):1041-1047. doi: 10.1080/1744666X.2017.1372194. Epub 2017 Sep 1.
7
SARS and MERS: recent insights into emerging coronaviruses.严重急性呼吸综合征和中东呼吸综合征：对新型冠状病毒的最新见解
Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27.
Zotero 插件